← Browse by Condition
Medical Condition
sezary syndrome
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT04930653 Phase 2
Recruiting
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
Enrollment
34 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT03587844 Phase 2
Recruiting
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
Enrollment
58 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...